Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Robotic-Assisted Medial Unicompartmental Knee Arthroplasty Provides Better FJS-12 Score and Lower Mid-Term Complication Rates Compared to Conventional Implantation: A Systematic Review and Meta-Analysis.
Avram GM, Tomescu H, Dennis C, Rusu V, Mengis N, Ammann E, Pacchiarotti G, Hirschmann MT, Predescu V, Russu O. Avram GM, et al. Among authors: ammann e. J Pers Med. 2024 Dec 3;14(12):1137. doi: 10.3390/jpm14121137. J Pers Med. 2024. PMID: 39728050 Free PMC article. Review.
Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.
Ye JC, Biran N, Nair S, Lin X, Qi K, Londhe A, Ammann E, Renaud T, Kane C, Parekh T, Gray K, Peterson S, Costa LJ. Ye JC, et al. Among authors: ammann e. Clin Lymphoma Myeloma Leuk. 2024 Aug 13:S2152-2650(24)00295-7. doi: 10.1016/j.clml.2024.08.003. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39271448
Matching-adjusted indirect comparison of talquetamab vs selinexor-dexamethasone and vs belantamab mafodotin in patients with relapsed/refractory multiple myeloma.
Reece D, Diels J, Van Sanden S, Pei L, Ammann E, Heuck C, Kane C, Londhe A, Peterson S, Chari A. Reece D, et al. Among authors: ammann e. Curr Med Res Opin. 2024 Oct;40(10):1769-1783. doi: 10.1080/03007995.2024.2391553. Epub 2024 Sep 3. Curr Med Res Opin. 2024. PMID: 39226081 Free article. Clinical Trial.
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.
Einsele H, Moreau P, Bahlis N, Bhutani M, Vincent L, Karlin L, Perrot A, Goldschmidt H, van de Donk NWCJ, Ocio EM, Martinez-Lopez J, Rodríguez-Otero P, Dytfeld D, Diels J, Strulev V, Haddad I, Renaud T, Ammann E, Cabrieto J, Perualila N, Gan R, Zhang Y, Parekh T, Albrecht C, Weisel K, Mateos MV. Einsele H, et al. Among authors: ammann e. Adv Ther. 2024 Apr;41(4):1576-1593. doi: 10.1007/s12325-024-02797-x. Epub 2024 Feb 24. Adv Ther. 2024. PMID: 38402374 Free PMC article.
Meniscal rim instability has a high prevalence and a variable location.
Ammann N, Kaelin R, Ammann E, Rutz E, Studer K, Valdarrabano V, Camathias C. Ammann N, et al. Among authors: ammann e. Arch Orthop Trauma Surg. 2023 Oct;143(10):6113-6116. doi: 10.1007/s00402-023-04908-9. Epub 2023 May 19. Arch Orthop Trauma Surg. 2023. PMID: 37208476 Free PMC article.
99 results